Pharmacovigilance in Contrast: A Comparative Analysis of ADR Reporting in India and Sub-Saharan Africa

Adverse Drug Reactions (ADRs) represent a tenacious global health concern, demanding robust pharmacovigilance systems to ensure drug safety and patient protection. This comparative study evaluates ADR reporting frameworks in India, Morocco, Liberia, and Tanzania, highlighting their operational differences, strengths, and key challenges. India's well-established Pharmacovigilance Programme (PvPI) employs both digital and manual mechanisms, yet suffers from significant underreporting driven by limited awareness and reluctance among healthcare professionals. In contrast, Morocco’s Directorate of Medicines and Pharmacy oversees a largely manual system that remains in its developmental phase, affecting data efficiency. Liberia’s system, coordinated by the Liberia Medicines and Health Products Regulatory Authority (LMHRA), is nascent and constrained by resource scarcity, inadequate training, and minimal public involvement. Tanzania’s system, under the Tanzania Medicines and Medical Devices Authority (TMDA), incorporates digital tools more effectively and demonstrates notable progress; however, underreporting and limited rural healthcare engagement continue to hinder its performance. A cross-country analysis reveals shared challenges, including low awareness, minimal patient engagement, lack of healthcare worker incentives, and inconsistent adoption of electronic platforms. The study recommends enhancing pharmacovigilance through targeted training, improved digital infrastructure, and integration with international networks such as the WHO Programme for International Drug Monitoring. Strengthening ADR reporting systems and fostering a culture of safety and accountability will not only improve national healthcare outcomes but also contribute to global pharmacovigilance efforts. Sustained policy evolution, increased stakeholder collaboration, and active public participation are crucial to building resilient and efficient ADR monitoring systems across diverse healthcare landscapes.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-05
DOI
https://doi.org/10.5281/zenodo.15597989
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacovigilance in Contrast: A Comparative Analysis of ADR Reporting in India and Sub-Saharan Africa

Zenodo (CERN European Organization for Nuclear Research)
Pharmacovigilance and Adverse Drug Reactions
article

Pharmacovigilance in Contrast: A Comparative Analysis of ADR Reporting in India and Sub-Saharan Africa

article en

Abstract

Adverse Drug Reactions (ADRs) represent a tenacious global health concern, demanding robust pharmacovigilance systems to ensure drug safety and patient protection. This comparative study evaluates ADR reporting frameworks in India, Morocco, Liberia, and Tanzania, highlighting their operational differences, strengths, and key challenges. India's well-established Pharmacovigilance Programme (PvPI) employs both digital and manual mechanisms, yet suffers from significant underreporting driven by limited awareness and reluctance among healthcare professionals. In contrast, Morocco’s Directorate of Medicines and Pharmacy oversees a largely manual system that remains in its developmental phase, affecting data efficiency. Liberia’s system, coordinated by the Liberia Medicines and Health Products Regulatory Authority (LMHRA), is nascent and constrained by resource scarcity, inadequate training, and minimal public involvement. Tanzania’s system, under the Tanzania Medicines and Medical Devices Authority (TMDA), incorporates digital tools more effectively and demonstrates notable progress; however, underreporting and limited rural healthcare engagement continue to hinder its performance. A cross-country analysis reveals shared challenges, including low awareness, minimal patient engagement, lack of healthcare worker incentives, and inconsistent adoption of electronic platforms. The study recommends enhancing pharmacovigilance through targeted training, improved digital infrastructure, and integration with international networks such as the WHO Programme for International Drug Monitoring. Strengthening ADR reporting systems and fostering a culture of safety and accountability will not only improve national healthcare outcomes but also contribute to global pharmacovigilance efforts. Sustained policy evolution, increased stakeholder collaboration, and active public participation are crucial to building resilient and efficient ADR monitoring systems across diverse healthcare landscapes.

Zenodo (CERN European Organization for Nuclear Research)
Industry, innovation and infrastructure
Openalex Percentile: Top 50%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pharmacovigilance in Contrast: A Comparative Analysis of ADR Reporting in India and Sub-Saharan Africa · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS